Physician profile
Michael S Mitri
NPI 1730314063
$7,484.53
in general payments reported to CMS, 2019-2025
20 companies · $6,265 in 2025
The $6,265 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $439 · 2020: $238 · 2021: $205 · 2022: $293 · 2023: $25.59 · 2024: $19.35 · 2025: $6,265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,500 · Travel and Lodging: $1,503 · Food and Beverage: $307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,500.00 |
| Travel and Lodging | $1,502.69 |
| Food and Beverage | $307.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,210.53 | 2025 | |
| Abbvie INC. | $261.45 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $140.39 | 2019-2022 | |
| Avion Pharmaceuticals | $135.80 | 2019-2020 | |
| Coopersurgical, INC. | $122.25 | 2021-2025 | Ally II Ups |
| Exeltis, USA INC. | $93.90 | 2019-2022 | |
| Amag Pharmaceuticals, INC. | $93.56 | 2019-2020 | |
| Allergan, INC. | $59.20 | 2019-2020 | |
| Therapeuticsmd, INC. | $56.53 | 2019-2021 | |
| Baxter Healthcare | $55.22 | 2022 | |
| Mission Pharmacal Company | $48.10 | 2019 | |
| Merck Sharp & Dohme LLC | $38.08 | 2019-2020 | |
| Ethicon US, LLC | $37.11 | 2020-2024 | Echelon Endopath |
| Vertical Pharmaceuticals, LLC | $28.59 | 2019 | |
| Ascend Therapeutics US, LLC | $25.15 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $19.79 | 2022 | |
| Organon LLC | $16.80 | 2021 | |
| Agile Therapeutics, INC. | $16.01 | 2022 | |
| Lupin INC. | $13.66 | 2019 | |
| Horizon Therapeutics Plc | $12.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mitri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.